Articles
| Open Access |
https://doi.org/10.37547/ijmscr/Volume02Issue11-02
CLINICAL AND NEUROLOGICAL FEATURES OF COVID-19 IN CHILDREN
Abstract
This article presents information about the clinical and neurological features of COVID-19 in children. A new coronavirus infection, COVID-19, caused by the SARS-CoV-2 virus, along with damage to the respiratory system, can lead to involvement of the central and peripheral nervous system and the muscular system. There is a relationship between the severity of COVID-19 and the severity and frequency of neurological disorders. The course of COVID-19 in children depends on age, premorbid background, the development of neurological complications that negatively affect the clinic of the disease.
Keywords
COVID-19, polyneuropathy, myalgia
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan , China. Lancet. 2020; 395:497-506. doi: 10.1016/S0140-6736(20)30183-5.
2.https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200612-covid-19-sitrep-144. pdf?sfvrsn=66ff9f4f_2 (accessed 12.06.2020).
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. Feb. 2020 24. doi: 10.1001/jama.2020.2648.
CDC COVID-19 Response Team. Coronavirus disease 2019 in children. United States, February 12—April 2, 2020. MMWR Morb. Mortal Wkly Rep. 2020 Apr 6. http://dx.doi.org/10.15585/mmwr. mm6914e4.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D'Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020 May 13. Epub ahead of print. doi: 10.1016/S0140-6736(20)31103-X.
Namazova-Baranova L.S. Coronavirus infection (COVID-19) in children (as of April 2020). Pediatric pharmacology. 2020; 17(2): 85-94. doi: 10.15690/pf.v17i2.2094.
Hennon TR, Penque MD, Abdul-Aziz R, Alibrahim OS, McGreevy MB, Prout AJ, Schaefer BA, Ambrusko SJ, Pastore JV, Turkovich SJ, Gomez-Duarte OG, Hicar MD. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach. Prog Pediatric Cardiol. May 2020 23:101232. Epub ahead of print. doi: 10.1016/j.ppedcard.2020.101232.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020 May 23;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1.